Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy ; volume:16 ; number:1 ; day:6 ; month:12 ; year:2018 ; pages:1-8 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (6.12.2018), 1-8, 12.2018
- Urheber
-
Medrano, Luz M.
Gutiérrez-Rivas, Mónica
Blanco, Julià
García, Marcial
Jiménez-Sousa, María A.
Pacheco, Yolanda M.
Montero, Marta
Iribarren, José Antonio
Bernal, Enrique
Martínez, Onofre Juan
Benito, José M.
Rallón, Norma
Resino, Salvador
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1717-y
- URN
-
urn:nbn:de:101:1-2019012522411204552969
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.06.2025, 04:11 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Medrano, Luz M.
- Gutiérrez-Rivas, Mónica
- Blanco, Julià
- García, Marcial
- Jiménez-Sousa, María A.
- Pacheco, Yolanda M.
- Montero, Marta
- Iribarren, José Antonio
- Bernal, Enrique
- Martínez, Onofre Juan
- Benito, José M.
- Rallón, Norma
- Resino, Salvador
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania
CD4+ guided antiretroviral treatment interruption. A meta-analysis
Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study
0234. Mitochondrial ageing and antiretroviral therapy exposure
Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania
CD4+ guided antiretroviral treatment interruption. A meta-analysis
Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study
0234. Mitochondrial ageing and antiretroviral therapy exposure
Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania
CD4+ guided antiretroviral treatment interruption. A meta-analysis
Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study
0234. Mitochondrial ageing and antiretroviral therapy exposure
Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Hematological Profile of HIV-Infected Patients on First-Line Highly Active Antiretroviral Therapy and Its Correlation With CD4 Count